Over the administration period was extended sufficient to establish a self-sustaining vascular, locally to the blood vessel wall from the implantable device, a method of treating vascular infarction heart provides the angiogenesis agent . In order to supply angiogenic agent one or more to promote angiogenesis, the expandable the medical device structure, the expandable medical device angiogenic agent supply includes an opening. Subsequently, the device may be, for example, to treat diseases and conditions associated with chronic total infarct, to supply multiple agents that promote angiogenesis.
展开▼